311 related articles for article (PubMed ID: 18645360)
1. Relationship between treatment resistance to hemoperfusion using a polymyxin B-immobilized fiber column and oxidative stress.
Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
ASAIO J; 2008; 54(4):412-5. PubMed ID: 18645360
[TBL] [Abstract][Full Text] [Related]
2. Early induction of PMX-DHP improves oxygenation in severe sepsis patients with acute lung injury.
Suyama H; Kawasaki Y; Morikawa S; Kaneko K; Yamanoue T
Hiroshima J Med Sci; 2008 Dec; 57(3-4):79-84. PubMed ID: 19260559
[TBL] [Abstract][Full Text] [Related]
3. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
ASAIO J; 2007; 53(3):324-8. PubMed ID: 17515723
[TBL] [Abstract][Full Text] [Related]
4. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome.
Tsushima K; Kubo K; Yoshikawa S; Koizumi T; Yasuo M; Furuya S; Hora K
Ther Apher Dial; 2007 Apr; 11(2):138-45. PubMed ID: 17381535
[TBL] [Abstract][Full Text] [Related]
5. Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome.
Nakamura T; Fujiwara N; Sato E; Kawagoe Y; Ueda Y; Yamada S; Koide H
ASAIO J; 2009; 55(4):395-9. PubMed ID: 19506468
[TBL] [Abstract][Full Text] [Related]
6. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock.
Mitaka C; Tsuchida N; Kawada K; Nakajima Y; Imai T; Sasaki S
Shock; 2009 Nov; 32(5):478-83. PubMed ID: 19295483
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S
Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
[TBL] [Abstract][Full Text] [Related]
8. Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock.
Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
ASAIO J; 2007; 53(5):646-50. PubMed ID: 17885340
[TBL] [Abstract][Full Text] [Related]
9. Criteria for direct hemoperfusion with an immobilized polymyxin B fiber column based on oxygen metabolism.
Kushi H; Miki T; Sakagami Y; Saito T; Tanjoh K
Ther Apher Dial; 2008 Aug; 12(4):292-7. PubMed ID: 18789116
[TBL] [Abstract][Full Text] [Related]
10. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
Yamashita C; Hara Y; Kuriyama N; Nakamura T; Nishida O
Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
[TBL] [Abstract][Full Text] [Related]
11. Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure.
Tojimbara T; Sato S; Nakajima I; Fuchinoue S; Akiba T; Teraoka S
Ther Apher Dial; 2004 Aug; 8(4):286-92. PubMed ID: 15274679
[TBL] [Abstract][Full Text] [Related]
12. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock.
Naka T; Shinozaki M; Akizawa T; Shima Y; Takaesu H; Nasu H
Ther Apher Dial; 2006 Feb; 10(1):7-11. PubMed ID: 16556130
[TBL] [Abstract][Full Text] [Related]
13. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
[TBL] [Abstract][Full Text] [Related]
14. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
[TBL] [Abstract][Full Text] [Related]
15. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation.
Kushi H; Miki T; Okamaoto K; Nakahara J; Saito T; Tanjoh K
Crit Care; 2005; 9(6):R653-61. PubMed ID: 16280061
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a historical control study and a review of previous studies.
Ichiyasu H; Horio Y; Masunaga A; Migiyama Y; Sakamoto Y; Jodai T; Ideguchi H; Okabayashi H; Hamada S; Yoshida C; Hirosako S; Okamoto S; Kohrogi H
Ther Adv Respir Dis; 2017 Jul; 11(7):261-275. PubMed ID: 28554260
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in septic shock patients treated with direct hemoperfusion with a polymyxin B-immobilized fiber column.
Ebihara I; Hirayama K; Kaneko S; Nagai M; Ogawa Y; Fujita S; Usui J; Mase K; Yamagata K; Kobayashi M
Ther Apher Dial; 2008 Aug; 12(4):285-91. PubMed ID: 18789115
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin Balance in Septic Shock Patients With Acute Kidney Injury: Effects of Direct Hemoperfusion With Polymyxin B-Immobilized Fiber.
Ebihara I; Hirayama K; Nagai M; Shiina E; Koda M; Gunji M; Okubo Y; Sato C; Usui J; Yamagata K; Kobayashi M
Ther Apher Dial; 2016 Aug; 20(4):368-75. PubMed ID: 27523077
[TBL] [Abstract][Full Text] [Related]
19. Early hemoperfusion with a polymyxin b column improves gastric intramucosal pH in sepsis.
Kushi H; Miki T; Sakagami Y; Sato J; Saito T; Tanjoh K
Ther Apher Dial; 2008 Aug; 12(4):278-84. PubMed ID: 18789114
[TBL] [Abstract][Full Text] [Related]
20. Hemoperfusion with an immobilized polymyxin B fiber column reduces circulating interleukin-8 concentrations.
Kushi H; Miki T; Nakahara J; Okamoto K; Kawahara Y; Saito T; Tanjoh K
Ther Apher Dial; 2006 Oct; 10(5):425-9. PubMed ID: 17096697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
